slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 234,421-234,450
Pages 10,126
Rows per page 30
Component
234,421-234,450 of 303,780
01
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
03
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
04
The slide uses a grid layout to present six distinct value propositions for the company.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
05
The slide uses a standard pharmaceutical pipeline visualization format.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Roadmap1 hit
06
The slide uses a four-column layout to structure the disease landscape.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
Uses a Venn/concentric circle diagram to show the funnel from total infected to diagnosed to treated.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Problem StatementLoop · Aha Moment1 hit
08
The slide uses a process-oriented flow diagram to explain the therapeutic strategy.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Aha Moment1 hit
09
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
10
The slide highlights the mechanism of action and key benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
11
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Key Takeaways1 hit
12
The slide outlines a clinical trial protocol with specific patient counts (n=43, 12, 13, 8, 10) and timeline milestones (weeks 1, 24, 28, 40, 52).Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
13
Data presented at EASL 2024. Includes specific patient counts and percentages for Cohorts A1 and A2.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
14
Data presented at EASL 2024. LLOQ = 0.05 IU/mL.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
15
The slide outlines two parallel study arms involving Imdusiran, VTP-300, NA, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Traction1 hit
05
Features an image of the Optimus robot.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · DesireLoop · Tale Two Worlds1 hit
06
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Interest1 hit
11
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · InterestLoop · Day In Life1 hit
12
The slide uses a three-column layout to present arguments against potential concerns regarding the move from Delaware to Texas.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Interest1 hit
14
Uses a causal logic flow to demonstrate alignment between CEO compensation and shareholder value.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Loop · Cost Of Inaction1 hit
15
Uses growth multipliers (15x, 22x, 12x) to emphasize the scale of the targets.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses external validation (authority bias) to frame the company's aggressive growth targets as historically significant and challenging.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
19
The slide uses testimonials to frame the legal dispute as a matter of 'stockholder democracy' rather than corporate governance.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
20
Uses a 'deal' framing to appeal to shareholder fairness and fiduciary consistency.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
21
Uses a before-after framing to address shareholder concerns.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations 1 hit
22
The slide uses a dark, high-contrast aesthetic typical of Tesla's corporate communications.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
23
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
24
This slide is part of a defense strategy to preemptively rebut concerns about board independence.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
25
Tesla | Shareholder Engagement Presentation Deck | 30 slidesTesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit
29
This is a web page screenshot acting as a navigation hub for investor materials.Tesla | Shareholder Engagement Presentation Deck | 30 slides · Tesla
Shareholder letter Investor relations Beat · Action1 hit